Role of mycoplasma hominis and ureaplasma urealyticum in patients with chronic prostatitis

ABSTRACT

This study was done to elucidate the role of Mycoplasma hominis [M. hominis] and Ureaplasma urealyticum [U. urealyticum] in patients with chronic prostatitis. The study was done on two groups. The first group included 50 male patients with chronic prostatitis, the second group included 10 normal subjects as controls. Urine samples before and after prostatic massage and prostatic secretions were collected from all patients and controls. Prostatic secretions were used for preparation of wet and Gram stained films, culture on conventional culture media and to inoculate Mycofast AlI- In trays. Conventional cultures revealed positive growth in 74% of cases. Strept faecalis and Staph epidermides were the commonest organisms isolated. 26% of cases and all the controls revealed no growth. The overall isolation rate of U. urealyticum and M. hominis was 12%. Each of U. urealyticum and M. hominis was detected in 4% of cases and both organisms occured in 4% of cases. All controls were negative for mycoplasmas. Regarding antibiotic susceptibility, all M. hominis and U. urealyticum strains were susceptible to minocycline, tetracycline and ciprofloxacin except one strain of U. urealyticum which was resistant to ciprofloxacine. We concluded that mycoplasmas may be considered as an aetiological agent in chronic prostatitis either solely or in combination with other bacteria. Also, it is concluded that mycofast All-In kit, which is a rapid and easy test, can be used for routine diagnosis of mycoplasma infections